of sensitivity of the IEF technique as suggested by others. We also tried the modified technique of Wilson et al. (10) with a pH 2.5-10.0 gradient instead of a pH 5-10 gradient and with a prefocus 30 min at 300 volts, but the detection of the CFP band was not improved.
Recently, this CFP specific material, isolated from polyacrylamide gel after electrofocusing, has been used with success by different groups to develop a quantitative immunoassay. Manson and Brock (1, 2) have raised antisera in guinea pigs and Wilson in mice ( 1 2). Both antisera allowed a quantitative distinction between CF homozygotes, heterozygotes, and controls. Even if there are still a number of unsolved problems such as blood collection and antiserum supply (I) , their data, which shows a difference in levels of CFP strongly argue that this protein may be a marker of cystic fibrosis. Our characterization of CFP in plasma as well as in serum demonstrates that this low molecular weight protein is present in blood before blood clotting and could permit a better standardization of blood collection, which looks critical for its evaluation.
In conclusion, we agree with many workers that the IEF technique is too delicate and not sufficiently sensitive to be used for diagnosis. This technique remains. however, the first step in identifying the CFP which seems to be closely associated with the CF gene and whose characterization would allow future investigation of the basic defect of the disease.
8. Wilson. G. B.. Jahn. T. L.. and Fonseca. J. R.: Demonstration ofserum protein differences In cyst~c fibrosis by isoelectric focusing in thin-layer polyacrylamide gels. Clin. Chim. Acta. 49 79 (1973) . 0. Wrlson. G. B.. Fudenberg, H. H.. and Jahn. T. L.: Stirdies on cystic fibrosis using isolelcctr~c focusing. An assay for detection of cystic fibrosrs honrozygotes and hetero~ygote carriers from serum. Pedlatr. Res. 9: 635 (1975 
Summary
We measured the concentrations of protein, insulin, and epidermal growth factor (EGF) in human milk from mothers delivering at term. Samples were obtained from d 1 (colostrum) to d 42 after birth. Human colostrum contains very high concentrations of protein i83.7 + 7.4 g/l (SEM)], insulin (3.75 2 0.88 nM), and EGF (53.9 f 6.9 nM). Similar concentrations have been measured in prebirth milk. Insulin, EGF, and protein in milk decline rapidly during the first few days of lactation but remain constant thereafter. Although the concentrations of insulin and EGF in mature milk are only 10% of those in colostrum, they are considerably higher than in serum. We also showed that human milk has a growth-promoting activity in cultured cells, causing a stimulation of protein synthesis in L6 myoblasts and 3T3-L1 fibroblasts and an increase in DNA synthesis in Llh cells and T47D breast cancer cells. This mitogenic activity declines as lactation progresses, with a similar time-course to the fall in insulin and EGF; however, the cell lines used here are not responsive to either of these two growth factors in the range of concentrations found in milk. This indicates that human milk also contains high concentrations of additional, unidentified growth factors. The occurrence of high concentrations of growth factors in milk suggests that they may be important for the proliferation and differentiation of infant tissues.
Abbreviations

EGF, epidermal growth factor PBS, phosphate buffered saline
A wide spectrum of hormones has been identified in milk, including prolactin, prostaglandins, thyroid hormones, glucocorticoids, thyroid stimulating hormone, and adrenocorticotropic hormone (20). More recently, milk has been shown to contain high concentrations of factors that promote the growth of cultured cells. Klagsbrun (17) first reported in 1978 that human milk contained a mitogenic factor that stimulated DNA synthesis and cell division in mouse and human fibroblasts in vitro, 1% milk having the potency of 10% fetal calf serum. Subsequent studies have shown that the response can be demonstrated in several cell types (2, 7, 18, 28, 3 I) and that bovine colostru~n is more active than mature milk (2, 18, 31) . EGF is one of the major growth-promoting factors in milk because most of the mitogenic activity of human milk on cultured human fibroblasts is lost after addition of antibodies against EGF (7) . Insulin also has a growth-promoting role because passage of colostrum through a column containing anti-insulin antibodies eliminates the inhibition of intracellular protein degradation in H35 and MH I C, hepatoma cells produced by unfractionated colostrum (2). It is apparent, however, that milk also contains other growth factors because colostrum is mitogenic in cultured cell lines that show little response to insulin or EGF (2).
The growth-promoting action of milk on cultured cells and the high concentration of EGF, and possibly of insulin, suggest that growth factors in milk may play an important role in the growth and differentiation of infant tissues. Accordingly, we have measured changes during lactation in the concentration of insulin and EGF in human milk and correlated these changes with its growth-promoting activity, estimated as the stimulation of DNA and protein synthesis in cultured cells.
MATERIALS AND METHODS
Milk samples. Samples of expressed breast milk were obtained from 23 mothers after delivery of full-term infants. The mean gestational age was 40 wk (range, 38-41 wk) and all pregnancies were considered normal and without significant maternal disease. Samples were taken daily for the first week after birth, and then weekly for a further 5 wk, with 18 of the 23 mothers completing the entire 6 wk collection period. Milk expressed before birth was also obtained from some women. All samples were expressed manually into polypropylene tubes and frozen (-15°C) immediately. Subsequently they were thawed, diluted with an equal volume of PBS comprising 10 mM KH2P04 and 0.9% (w/v) NaCI, pH 7.4, and centrifuged at 100,000 g for 60 min. The infranatants were recovered by aspiration and stored at -15°C.
Cell cultzire. L6 rat myoblasts, 3T3-L1 mouse fibroblasts, and AG2804 Simian virus 40-transformed human lung fibroblasts were kindly provided by Dr. J.M. Gunn, Department of Biochemistry and Biophysics, Texas A and M University, College Station, TX and T47D human cancer breast cells by Professor T.J. Martin, Department of Medicine, University of Melbourne, Repatriation General Hospital, West Heidelberg, Victoria 3077, Australia.
Uniform numbers of cells were added to Costar 24-well plates, and grown in Dulbecco-modified Eagle's minimal essential medium containing 5% (v/v) fetal calf serum together with 50 mg gentamycin, 100 mg streptomycin sulphate, and 60 mg penicillin G per litre (growth medium). All measurements were canied out on confluent monolayers.
h4easurement ~finsulin concentration. Insulin in milk infranatants was determined by radioimmunoassay (12) with porcine insulin as the standard. Identical concentrations were measured using human insulin standard (results not shown). ["'I]Insulin (specific activity, 50 ~C i l~g ) was prepared using 1,3,4,6-tetrachloro-3a,6a-diphenylg1ycoluril (Iodogen) (I I).
Measllrement ~f EGF. EGF was measured by a radioreceptor assay using murine EGF as the standard together with ["'I] labeled murine EGF. EGF was iodinated to a specific activity of 50 ~C i l~g using the Iodogen method (1 1). Binding of EGF to monolayers of AG2804 fibroblasts (approximately 150 pg protein per monolayer) was determined in triplicate in Hanks' salts, pH 7.4 containing 0.1 % (w/v) bovine serum albumin. Confluent monolayers were washed twice with this solution over a period of 60 min at 37°C. Fresh salts containing ["'IIEGF (approximately 0.8 ng, 0.04 pCi) and standard EGF or milk infranatants were then added in a total volume of 500
Dishes were incubated at 24°C for 90 min before being washed five times at 4°C with Hanks' salts without albumin. Monolayers were dispersed by trituration in 1 ml of 0.5 M NaOH containing 0.1 % (w/v) Triton XlOO for the measurement of radioactivity and protein.
Protein synthesis measurements. Monolayers of L6 myoblasts and 3T3-L1 fibroblasts were incubated at 37°C with 1 ml of labeling medium (serum-free growth medium to which 0.5 mmol of leucine had been added per litre). After 2 h, fresh labeling medium containing I FCi ['H]leucine and the sample to be tested (100 p1) were added in a total volume of 1 ml. Samples included milk infranatants. purified growth factors or fetal calf serum. Control wells contained 100 p1 PBS. Dishes were incubated for 18 h at 37°C with a gas phase of 5% CO. in air before the medium was removed, and the monolayers washed twice with 1 ml 5% (wjv) trichloroacetic acid during a 10-min period. Monolayers were finally rinsed with 2 ml distilled water before digestion in 1 ml 0.5M NaOH containing 0.1 % (w/v) Triton X100. Radioactivity was measured after trituration using an NCS-based scintillation fluid (19). Total radioactivity in these digests was interpreted as radioactivity in cell protein because it was found that material soluble in trichloroacetic acid contained insignificant amounts of label. Protein synthesis was expressed as counts/min of ['Hlleucine incorporated into cell protein.
Measurement of DNA synthesis. Monolayers of L6 myoblasts and T47D breast cancer cells were washed for 2 h at 37°C with I ml labeling medium containing 5 pM thymidine. This was then replaced by 900 ~1 fresh medium together with 100 ~1 PBS (controls) or sample as described for protein synthesis. Cultures were incubated at 37°C for 18 h before addition of 1 pCijm1 of ['Hlthymidine. After a further 6-h incubation at 37"C, monolayers were washed, digested, and counted as for protein synthesis.
Protein determinations. Protein concentrations in milk infranatants and in digested cell monolayers were measured by an Auto Analyser adaptation of the method of Dulley and Grieve (lo), who used bovine serum albumin as the standard.
Materials. Culture media were purchased from Gibco, Grand Island, NY, U.S.A. and fetal calf serum from Commonwealth Serum Laboratories, Melbourne, Australia. Iodogen was obtained from Pierce Chemical Co., Rockford, IL, U.S.A.; Na["'I] (16 mCijpg iodide), I<- [4,5-3H] leucine (40-60 Ci/mmol), and were from the Radiochemical Centre, Amersham, U.K. Unlabeled insulin was Actrapid from Novo Industri A/S, Copenhagen, Denmark. EGF was generously provided by Dr. J.H. Koch, CSIRO, Molecular and Cellular Biology Unit, North Ryde, N.S.W., Australia. Antibodies used in insulin radioimmunoassays were obtained from Wellcome Australia Ltd., Rosebeny, New South Wales, Australia and NCS solubiliser was a product of Amersham Corporation, Arlington Heights, Illinois, U.S.A. Sephadex G50 superfine resin was obtained from Pharmacia Fine Chemicals, Uppsala, Sweden.
RESULTS
Growthfactors in tnillc.
Evidence for the identity of the material assayed by radioreceptor and immunoassays was obtained by chromatographing human milk on a Sephadex G50 column as described in Figure 1 . EGF and insulin were recovered quantitatively from the column and 90% of the activity measured by receptor (EGF) or radioimmunoassay (insulin) eluted in a single peak. Both insulin and EGF activity chromatographed slightly earlier than the ['"I]labeled standards, but because there was only a slight difference in elution volume, it appears likely that the material assayed in milk is insulin and EGF, and does not include any high molecular weight forms. The difference in chromatographic behaviour between unlabeled and ["'I] peptides may result from effects of iodination on molecular weight, shape, and charge distribution.
Concentrations of EGF and insulin in milk infranatants were proportional to the volumes assayed. Added standards were recovered quantitatively in the presence of these samples (data not shown).
The concentration of insulin in day 1 colostrum shows considerable variability between mothers, with a range of 0.59-15.36 nM. Nevertheless, the concentration in all samples is much higher than that in serum; the mean [3.75 & counts/m~n) was applied to a 0.9 x 60 cm column of Sephadex G50 superfine. equilibrated with phosphate buffered saline containing 1.5 mg/ ml bovine scrum albumin. Elution was carried out in the same solution. at room temperature with a flow rate of 0.1 1 ml/min. Fraction volume was I ml and insulin, EGF and radioactivity were measured in each fraction. Over 90% of added EGF, insulin or ['2i1 ]-peptides were recovered from the colunln. EGF and insulin contents of each fraction are expressed as a percentage of the total amount of peptide recovered from the column. concentrations in pre-birth milk and colostrum are similar (Table  1 ). Figure 2a shows that the concentration of insulin in milk falls rapidly during the first 3 d of lactation and then shows no further decline. The basal level in mature milk [0.46 -t 0.05 (SEM) nM, n = 181, measured after 42-46 d of lactation is only 16% of the concentration on the first day of lactation but is still several-fold higher than in serum.
The EGF concentrations in colostrum [53.9 * 6.9 (SEM) nM, n = 171 and pre-birth milk (Table I ) are approximately 2000-fold greater than in serum (14). As with insulin, variability between mothers is high [range 23.3-125.0 nM in colostrum] and the EGF concentration declines rapidly during the first few days of lactation, although approximately 2 wk are required to reach a basal concentration (Fig. 2b) . The EGF content of mature milk [4.9 t 0.4 (SEM) nM, n = 171, measured after 42-415 d of lactation is more than 100-fold greater than in serum.
The protein concentration of human colostrum is 83.7 7.4 (SEM) g/l fat-free infranatant ( n = 18) and Table 1 shows that similar concentrations are found in pre-birth milk. There is a marked decline in protein during the first week of lactation to a basal concentration, which is 10% of that in colostrum (Fig. 3a) . The concentrations of protein, insulin, and EGF fall at similar rates, so that insulin and EGF expressed per gram of protein show little change as lactation progresses (Fig. 3b) .
EIficts of milk or1 DNA and protein svnthesis in cultured cells. In order to assess the growth-promoting activity of human milk in different tissues, we have used L6 myoblasts, 3T3-L1 fibroblasts, and T47D breast cancer cells that originate from muscle, adipose, and breast tissue, respectively. Human milk stimulates protein synthesis in both L6 myoblasts and 3T3-L1 fibroblasts (Fig. 4) . Colostrum assayed at a concentration of 2% (v/v) is nearly as potent as 5% (v/v) fetal calf serum and a significant stimulation is apparent with 0.5% colostrum. This effect diminishes during the first 3 d of lactation although protein synthesis in the presence of 2% mature milk remains significantly higher than the control rate in both of these cell lines. Colostrum at 2% increases the rate of DNA synthesis in L6 myoblasts to approximately 300% of the control value (Fig. Sa) , but in contrast to its effects on protein synthesis, 2% colostrum is much less potent than 5 % fetal calf serum in stimulating DNA synthesis in L6 cells and 0.5% colostrum has no significant effect. The stimulation of DNA synthesis by 2% milk declines over the first 5 d of lactation and milk obtained after this time reduced DNA synthesis in L6 myoblasts below the control rate.
A different response to milk is seen with DNA synthesis in T47D breast cancer cells. In this cell line, 0.5% colostrum produces a near-maximal stimulation of thymidine incorporation and is more potent than 5% fetal calf serum (Fig. 5b) . The stimulation of DNA synthesis by 2% milk declines only slightly as lactation progresses, but at a submaximal concentration (0.5%), it is apparent that colostrum is more potent than mature milk.
Rcsponsc c f c u l t~~r c d cell lines to in.rzJin utzd EGF.
The high concentrations of insulin and EGF in human colostrum suggest that these growth factors may account for a large proportion of the stimulation by milk of DNA and protein synthesis in cultured cells. This has been tested by incubating cells in the presence of the concentrations of EGF and insulin in milk. In assays containing 2% milk, cells are exposed to EGF concentrations ranging from lo-" (colostrum) to lo-"' M (mature milk) and insulin concentrations of 5 x lo-' ' to lo-" M (Fig. 2) . We have found that L6 myoblasts show little response to these growth factors; 1 0 -" -1 0~~ EGF does not stimulate protein or DNA synthesis synthesis in L6 myoblasts and can account for only 10% and 20% of the response to colostrum in 3T3-L1 fibroblasts and T47D cells. respectively.
Our results show that human milk contains high concentrations of insulin and EGF. The insulin concentration in colostrum is 40-fold greater than in serum and although this declines sharply during the first 3 d of lactation, it remains for at least 6 wk at a concentration that is several-fold higher than in blood. A decline in insulin during lactation has also been observed by Cevreska EGF, in contrast to insulin, cannot be measured accurately by radioimmunoassay without use of homologous hormone as standard because anti-mouse EGF is less than 0.1 % as reactive with human EGF as with mouse EGF (14). We have used a radioreceptor assay with cultured human AG2804 fibroblasts because interspecies differences are generally much less in receptor assays than with radioimmunoassays (14, 24). It has been shown that mouse and human EGF compete identically with ['"I]labeled mouse EGF for binding to receptors on human placental membranes (24) and with similar potency in human foreskin fibroblasts (15). It has not been determined whether mouse and human EGF compete identically with ["'I]labeled mouse EGF for binding to AG2804 fibroblasts, but we have obtained indirect evidence in support of this conclusion. Using AG2804 cells and Figure 2b is similar to that determined by radioimmunoassays using human EGF standard (30). It therefore appears likely that human EGF is measured accurately in receptor assays using AG2804 fibroblasts and murine EGF standard.
EGF in human colostrum and mature milk exceeds the serum concentration by 2000-and 200-fold, respectively (14) . Milk from other species also contains high concentrations of EGF hut there is considerable interspecies variation. We have measured 2 nM EGF in cow colostrum and 10-20 nM in colostrum from pigs and sheep whereas mature mouse milk is reported to contain 33-66 nM EGF (6) . The insulin concentration in milk also varies between species: sheep, cow, and human colostrum contain 2-3 nM insulin but pig colostrum contains approximately 10 JIM insulin. In addition to these differences among species, we have observed a high degree of variability among individual donor:; in the protein, insulin and EGF concentrations in human colostrum. This is probably due, in part, to the time of sampling. Most mothers provided only one sample of colostrum, expressed within 12 h after birth. In cases where more than one sample was provided, it was clear that insulin, EGF, and protein declined markedly within several hours of the onset of lactation, a change also observed in sheep, cow, and pig colostrum. Nevertheless, the time of sampling cannot account for most of the variability because we have measured a wide range of EGF and insulin concentrations after quantitative collection of colostrum from sheep and cows under conditions where suckling was not permitted.
It has not been clearly established whether insulin and EGF in milk originate from blood or are synthesised in the mammary gland. Beck and Tucker (3) calculated from arteriovenous differences and milk production rates that insulin in cow's milk can be derived entirely from the blood, a conclusion supported by Cevreska el al. (8) who reported a close correlation between insulin concentrations in human plasma and milk. Less information is available on the origin of EGF but it has been shown that radioactively labeled EGF can pass from the circulation into milk (4) .
We have shown that human milk stimulates protein and DlNA synthesis in several lines of cultured cells and, in agreement with previous studies using bovine milk (2, 18, 31) , colostrum has a much higher activity than mature milk. It has been reported1 for some cell lines that insulin (2) or EGF (7) can account for most of the mitogenic activity of milk. Although Figures 4 and 5 show that changes in the growth-promoting activity of milk in L6, 3T3-L1, and T47D cells parallel the fall in insulin and EGIF, it is apparent from 
Measurement of Total Respiratory Resistance in
Children by a Modified Forced Oscillation Method
Total respiratory resistance (R,) was measured in 11 normal children, 2-5.5 years of age (mean 4.16 years), and in 24 children with bronchial asthma, 2-10.5 years of age (mean 6 years), by oscillating the respiratory system from 2-32 H z with a new microprocessor technique. Twenty-five children were 5 5 years of age. This technique was also compared with airway resistance (Raw) by body plethysmography both in terms of baseline values and response to bronchodilators. The absolute values for Raw are lower than R I with a mean percentage difference (4S.E.M.) of 30.3 2 5.0%; however, good correlation between the two techniques was obtained ( r = 0.79). The changes of R1 and Raw were not significantly different after aerosolized isoproterenol (P > 0.05). We determined the inverse relationship between height and R , with correlation coefficient r = -0.79 (P < 0.01). In children, resonant frequency ranged from 6-24 H z with a mean value of 16.57 4 0.78 Hz. The forced oscillation method utilized clinically in this study provides an alternative to total body plethysmography or an esophageal balloon, which are technically difficult and preclude their routine use in small children.
In conclusion, R l utilized in this study is a rapid and reproducible approximation of Raw. It allows evaluation of R , over a wide range of frequencies including resonant frequency and requires less cooperation than body plethysmography. It requires a relatively short time and allows objective assessment of obstructive airway disease and its responsiveness to bronchodilators in children under 5 years of age. Abbreviations F.O., forced oscillation f,, resonant frequency Hz, Hertz, which equals cycles per second Raw, airway resistance R.,., total respiratory resistance Objective assessment of obstructive airway disease requires cooperation and therefore has limited use in children under 6 years of age. In this age group the distinction between normals and those with airway obstruction such as asthmatics or cystic fibrosis patients usually has been based on clinical evaluation. Furthermore, in those children who were diagnosed as having bronchial asthma, the degree of their obstructive airway reversibility after treatment with bronchodilators could not be evaluated nor followed objectively.
Measurements of total respiratory resistance (R-I ) by oscillating a sine wave of airflow to the mouth was first described by DuBois et a/. (3, 4) and later applied to children ( 2 , 9, 1 1-13). This F.O. method has been utilized clinically and provides an alterna1.ive to total body plethysmography or an esophageal balloon, both of which are technically difficult and therefore preclude routine use in small children. Because R-I is the sum of airway resistance and tissue resistance (including chest wall), values should approximate total lung resistance by the esophageal balloon (2, 5, 6) .
The F.O. technique is based on the theory that when a sine wave of airflow is applied to the tracheobronchial tree during spontaneous breathing, the changes in transthoracic pressure are directly related to the total impedance of the system (2, 5, 6) . The total impedance is composed of three elements: effective resistance, inertia, and elastic compliance (5, 6) . At very low frequencies, less than 2 Hz, elastic impedance dominates but at very high frequencies (above 10 Hz) inertial impedance dominates (2, 5-7). Between 5-25 Hz, (called the resonant frequency) the inertial and elastic components are of equal magnitude and opposite in sign, and therefore cancel each other. At resonant frequency, pressure and flow are in phase (zero phase angle). Total respiratory resistance can then be calculated from the relationship between pressure and flow, both measured at the mouth of the subject (4, 5, 7) . The mathematical expression of pressure change across the respiratory system include:
where A P represents pressure change, V, the resulting volume; V, the flow rate; V, the volume acceleration; C, the total respiratory compliance; R, the flow resistance; and I, the mass inertia.
A P At resonant frequency A P = RV and therefore R = -. 
